Variant report

Variant	nsv589283
Chromosome Location	chr3:234309-363254
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:651)
CpG islands
(count:1770)
Chromatin interactive
region (count:8)
LncRNA
region (count:25)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:651 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:305517-307368	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:291259-291870	HepG2	liver:	n/a	n/a
3	ATF2	chr3:319964-320748	GM12878	blood:	n/a	n/a
4	ATF2	chr3:331761-332103	GM12878	blood:	n/a	n/a
5	ATF2	chr3:319829-320847	GM12878	blood:	n/a	n/a
6	ATF2	chr3:254017-254518	GM12878	blood:	n/a	n/a
7	ATF2	chr3:254098-254530	GM12878	blood:	n/a	n/a
8	ATF3	chr3:306304-306760	A549	lung:	n/a	n/a
9	BACH1	chr3:238302-238499	H1-hESC	embryonic stem cell:	n/a	n/a
10	BACH1	chr3:238826-240389	H1-hESC	embryonic stem cell:	n/a	n/a
11	BACH1	chr3:271174-271333	K562	blood:	n/a	n/a
12	BATF	chr3:320384-320805	GM12878	blood:	n/a	n/a
13	BATF	chr3:259675-259847	GM12878	blood:	n/a	n/a
14	BATF	chr3:254085-254416	GM12878	blood:	n/a	n/a
15	BATF	chr3:341729-341996	GM12878	blood:	n/a	n/a
16	BATF	chr3:319974-320310	GM12878	blood:	n/a	n/a
17	BATF	chr3:319906-320293	GM12878	blood:	n/a	n/a
18	BCL11A	chr3:319927-320341	GM12878	blood:	n/a	chr3:320201-320210 chr3:320061-320069
19	BCL11A	chr3:319942-320280	GM12878	blood:	n/a	chr3:320201-320210 chr3:320061-320069
20	BCL3	chr3:306168-306863	A549	lung:	n/a	chr3:306285-306294 chr3:306282-306291
21	BCL3	chr3:320464-320727	GM12878	blood:	n/a	n/a
22	BCL3	chr3:306315-306750	A549	lung:	n/a	n/a
23	BCLAF1	chr3:320388-320763	GM12878	blood:	n/a	n/a
24	BHLHE40	chr3:306286-306823	HepG2	liver:	n/a	n/a
25	BHLHE40	chr3:342270-342502	GM12878	blood:	n/a	n/a
26	BHLHE40	chr3:260263-260618	GM12878	blood:	n/a	n/a
27	BHLHE40	chr3:260829-261058	GM12878	blood:	n/a	n/a
28	BHLHE40	chr3:319378-320826	GM12878	blood:	n/a	n/a
29	BRCA1	chr3:306367-306903	Hela-S3	cervix:	n/a	n/a
30	BRCA1	chr3:306406-306600	HepG2	liver:	n/a	n/a
31	CCNT2	chr3:238979-239034	K562	blood:	n/a	n/a
32	CEBPB	chr3:291542-291836	HepG2	liver:	n/a	chr3:291705-291716
33	CEBPB	chr3:306097-307016	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
34	CEBPB	chr3:279120-279410	A549	lung:	n/a	chr3:279226-279239 chr3:279227-279238
35	CEBPB	chr3:284758-286178	IMR90	lung:	n/a	chr3:284916-284933 chr3:285984-286001 chr3:284887-284900
36	CEBPB	chr3:302689-302981	Hela-S3	cervix:	n/a	chr3:302812-302825
37	CEBPB	chr3:306264-306781	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
38	CEBPB	chr3:243976-244300	IMR90	lung:	n/a	chr3:244109-244120
39	CEBPB	chr3:242500-242742	K562	blood:	n/a	n/a
40	CEBPB	chr3:306243-306864	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
41	CEBPB	chr3:306278-306814	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
42	CEBPB	chr3:291583-291816	HepG2	liver:	n/a	chr3:291705-291716
43	CEBPB	chr3:306302-306792	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
44	CEBPB	chr3:306266-306559	MCF-7	breast:	n/a	chr3:306309-306322 chr3:306463-306480
45	CEBPB	chr3:243949-244303	HepG2	liver:	n/a	chr3:244109-244120
46	CEBPB	chr3:306282-306969	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
47	CEBPB	chr3:242447-242817	IMR90	lung:	n/a	n/a
48	CEBPB	chr3:242488-242808	A549	lung:	n/a	n/a
49	CEBPB	chr3:243974-244307	A549	lung:	n/a	chr3:244109-244120
50	CEBPB	chr3:242440-242811	HepG2	liver:	n/a	n/a

(count:1770 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:285234-285284	HNPCEpiC	eye:	n/a
2	chr3:285234-285284	HNPCEpiC	eye:	n/a
3	chr3:350602-350652	BE2_C	brain:	n/a
4	chr3:238318-238368	Caco-2	colon:	n/a
5	chr3:350892-350942	MCF10A-Er-Src	breast:	n/a
6	chr3:351003-351053	MCF10A-Er-Src	breast:	n/a
7	chr3:353166-353216	NT2-D1	testis:	n/a
8	chr3:350892-350942	HAEpiC	amniotic membrane:	n/a
9	chr3:238161-238211	NHBE	bronchial:	n/a
10	chr3:239188-239238	ProgFib	skin:	n/a
11	chr3:236078-236128	HPAEpiC	pulmonary alveolar:	n/a
12	chr3:350503-350553	HCF	heart:	n/a
13	chr3:271185-271235	SKMC	muscle:	n/a
14	chr3:350789-350839	HMEC	breast:	n/a
15	chr3:240139-240189	HCM	heart:	n/a
16	chr3:240139-240189	IMR90	lung:	fetal
17	chr3:238496-238546	ECC-1	luminal epithelium:	n/a
18	chr3:239665-239715	AG04450	lung:	fetal
19	chr3:243996-244046	HCF	heart:	n/a
20	chr3:350602-350652	T-47D	breast:	n/a
21	chr3:239207-239257	GM12892	blood:	n/a
22	chr3:238318-238368	GM12891	blood:	n/a
23	chr3:238618-238668	PFSK-1	brain:	n/a
24	chr3:238931-238981	T-47D	breast:	n/a
25	chr3:236078-236128	SAEC	small airway:	n/a
26	chr3:350503-350553	GM12878	blood:	n/a
27	chr3:347869-347919	PFSK-1	brain:	n/a
28	chr3:239229-239279	HL-60	blood:	n/a
29	chr3:238615-238665	PrEC	prostate:	n/a
30	chr3:238161-238211	SKMC	muscle:	n/a
31	chr3:239207-239257	NH-A	brain:	n/a
32	chr3:240139-240189	MCF10A-Er-Src	breast:	n/a
33	chr3:350602-350652	RPTEC	kidney:	n/a
34	chr3:350789-350839	HCM	heart:	n/a
35	chr3:238392-238442	GM19239	blood:	n/a
36	chr3:353166-353216	HRCEpiC	kidney:	n/a
37	chr3:350789-350839	NHBE	bronchial:	n/a
38	chr3:350682-350732	GM12892	blood:	n/a
39	chr3:238496-238546	SKMC	muscle:	n/a
40	chr3:239207-239257	SK-N-SH	brain:	n/a
41	chr3:238318-238368	HepG2	liver:	n/a
42	chr3:353166-353216	MCF10A-Er-Src	breast:	n/a
43	chr3:238161-238211	GM12892	blood:	n/a
44	chr3:238615-238665	HCT-116	colon:	n/a
45	chr3:238611-238661	LNCaP	prostate:	n/a
46	chr3:238048-238098	NHBE	bronchial:	n/a
47	chr3:238048-238098	HCF	heart:	n/a
48	chr3:239207-239257	SK-N-MC	brain:	n/a
49	chr3:238618-238668	HEEpiC	esophagus:	n/a
50	chr3:347869-347919	CMK	blood:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
2	chr3:321596..323780-chr3:337949..340526,2	MCF-7	breast:
3	chr3:297411..299702-chr3:300779..302869,2	K562	blood:
4	chr3:321596..323780-chr3:337949..340526,2	MCF-7	breast:
5	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
6	chr3:297411..299702-chr3:300779..302869,2	K562	blood:
7	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:
8	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:

(count:25 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
2	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
3	lnc-CNTN6-7	chr3:254887-255362	NONHSAT087562
4	lnc-CNTN6-7	chr3:288251-290282	NONHSAT087561
5	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
6	lnc-IL5RA-6	chr3:238139-238386	NONHSAT087559
7	lnc-CNTN6-7	chr3:238454-238746	NONHSAT087560
8	lnc-CNTN6-7	chr3:239326-239775	NONHSAT087561
9	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
10	lnc-IL5RA-6	chr3:238290-238385	ENSG00000224318.1
11	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
12	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087560
13	lnc-IL5RA-6	chr3:237540-237597	NONHSAT087559
14	lnc-CNTN6-7	chr3:288251-288539	NONHSAT087560
15	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087561
16	lnc-IL5RA-6	chr3:238290-238542	ENSG00000224318.1
17	lnc-CNTN6-7	chr3:239697-239775	NONHSAT087562
18	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
19	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
20	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
21	lnc-IL5RA-6	chr3:238650-239024	ENSG00000224318.1
22	lnc-IL5RA-6	chr3:237679-237723	NONHSAT087559
23	lnc-IL5RA-15	chr3:350397-351005	NONHSAT087564
24	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
25	lnc-IL5RA-6	chr3:238650-238882	ENSG00000224318.1

No data

Variant related genes	Relation type
RNU6-1194P	TF binding region
RPS8P6	TF binding region
CHL1	TF binding region
CHL1-AS2	TF binding region
RNU6-1194P	CpG island
RPS8P6	CpG island
CHL1	CpG island
CHL1-AS2	CpG island

Extended variants
information (count: 6428 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:6428 , 50 per page) page: 1 2 3 4 5 6 7 ... 129

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111482717	chr3:234317-234318	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs550196022	chr3:234329-234330	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs571954120	chr3:234359-234360	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs538601466	chr3:234366-234367	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs546241958	chr3:234368-234369	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs553759183	chr3:234370-234371	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs370779805	chr3:234399-234400	Bivalent/Poised TSS Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs370878789	chr3:234429-234430	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs138911566	chr3:234436-234437	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs576869345	chr3:234440-234441	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs541082367	chr3:234449-234450	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs116810567	chr3:234457-234458	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs529686739	chr3:234463-234464	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs368786980	chr3:234481-234482	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548538286	chr3:234487-234488	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs13086137	chr3:234489-234490	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs530771599	chr3:234506-234507	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs552087561	chr3:234511-234512	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs570584169	chr3:234513-234514	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs7645802	chr3:234522-234523	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs140079095	chr3:234531-234532	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs547839290	chr3:234539-234540	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs112271501	chr3:234541-234542	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs550694247	chr3:234552-234553	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs544437900	chr3:234555-234556	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs370860944	chr3:234577-234578	Bivalent/Poised TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs377398121	chr3:234604-234605	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs562640113	chr3:234620-234621	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs570014123	chr3:234625-234626	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs7632791	chr3:234670-234671	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs558896760	chr3:234696-234697	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs544982494	chr3:234697-234698	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs577333939	chr3:234704-234705	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs186437395	chr3:234715-234716	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs553087578	chr3:234716-234717	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs7632811	chr3:234726-234727	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs541841955	chr3:234739-234740	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs563227651	chr3:234740-234741	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs371068756	chr3:234748-234749	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs374328972	chr3:234763-234764	Bivalent/Poised TSS Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs527310101	chr3:234807-234808	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs371641237	chr3:234808-234809	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs528265614	chr3:234842-234843	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs374960582	chr3:234846-234847	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs17044266	chr3:234877-234878	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs534566432	chr3:234886-234887	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs573544248	chr3:234891-234892	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs530085085	chr3:234898-234899	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs372817401	chr3:234910-234911	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs116355518	chr3:234929-234930	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Hodgkin''s lymphoma	17606441	CNVD

Chromatin state (count:775 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:233600-234400	Enhancers	Primary B cells from peripheral blood	blood
2	chr3:233800-235000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
3	chr3:234200-234800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
4	chr3:234600-234800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
5	chr3:235000-235200	Enhancers	Fetal Brain Female	brain
6	chr3:235000-236000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
7	chr3:235200-236000	Weak transcription	Fetal Brain Female	brain
8	chr3:235400-236600	Enhancers	Fetal Brain Male	brain
9	chr3:235800-236000	Enhancers	Adipose Nuclei	Adipose
10	chr3:235800-236400	Enhancers	Spleen	Spleen
11	chr3:235800-237000	Enhancers	Ovary	ovary
12	chr3:236000-236200	Flanking Active TSS	Adipose Nuclei	Adipose
13	chr3:236000-236400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
14	chr3:236000-236600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
15	chr3:236000-236800	Enhancers	Fetal Brain Female	brain
16	chr3:236200-236400	Enhancers	Brain Cingulate Gyrus	brain
17	chr3:236200-236400	Enhancers	Brain Substantia Nigra	brain
18	chr3:236200-237800	Enhancers	Breast Myoepithelial Primary Cells	Breast
19	chr3:236400-237000	Enhancers	Brain Germinal Matrix	brain
20	chr3:236400-237400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr3:236400-238200	Weak transcription	Spleen	Spleen
22	chr3:236600-237200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
23	chr3:236600-237200	Flanking Active TSS	Fetal Brain Male	brain
24	chr3:236800-238000	Active TSS	Fetal Brain Female	brain
25	chr3:237000-237200	Active TSS	Brain Germinal Matrix	brain
26	chr3:237000-237800	Enhancers	Cortex derived primary cultured neurospheres	brain
27	chr3:237000-237800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr3:237000-240400	Active TSS	Ovary	ovary
29	chr3:237200-237400	Flanking Active TSS	Brain Germinal Matrix	brain
30	chr3:237200-237600	Active TSS	Brain Cingulate Gyrus	brain
31	chr3:237200-237800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
32	chr3:237200-240000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr3:237200-240200	Active TSS	Brain Anterior Caudate	brain
34	chr3:237200-241000	Active TSS	Brain Angular Gyrus	brain
35	chr3:237200-241000	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
36	chr3:237200-241000	Active TSS	Fetal Brain Male	brain
37	chr3:237400-237600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
38	chr3:237400-241200	Active TSS	Brain Inferior Temporal Lobe	brain
39	chr3:237600-237800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
40	chr3:237600-237800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
41	chr3:237600-240000	Bivalent/Poised TSS	Brain Germinal Matrix	brain
42	chr3:237600-240200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
43	chr3:237600-241200	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
44	chr3:237800-238000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
45	chr3:237800-238000	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr3:237800-238000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
47	chr3:237800-238000	Active TSS	Brain Substantia Nigra	brain
48	chr3:237800-238200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
49	chr3:237800-238200	Bivalent Enhancer	Primary B cells from cord blood	blood
50	chr3:237800-238200	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links